ANI Pharmaceuticals is building a leading Rare Disease company focused on Serving Patients, Improving Lives

RECENT NEWS

ANI Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 5, 2026 at 8:00 a.m. ET

2026-10-23

READ MORE >

ANI Pharmaceuticals Announces the Launch of Duloxetine Delayed-Release Capsules

2026-10-19

READ MORE >

NASDAQ - ANIP

$72.61

-1.14 (-1.55%)

Pricing delayed by 20 minutes
Last updated 2026-10-23 16:00:00